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MinireviewFoxp3 and Natural Regulatory
T Cells: Key to a Cell Lineage?
activity (Groux et al., 1997; Levings et al., 2001; Sund-
stedt et al., 2003; Thorstenson and Khoruts, 2001). Many
different methods have been used to generate these
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induced (or adaptive) TR cells, but in general, the re-Bothell, Washington 98021
sulting cells mediate suppression mainly through the
production of suppressive cytokines such as IL-10 and
TGF. It seems likely that these cells represent altered
states of differentiation rather than a unique cell lineage.The recent characterization of a mutant strain of mice
Precisely what governs the shift of CD425 T cellsgenerated five decades ago in a program to study
toward this function is unclear, although numerous path-ionizing radiation in mammals (and, ironically, derived
ways are implicated, including activation by immaturefrom a nonmutagenized control animal) is helping to
DCs (Jonuleit et al., 2000; Wakkach et al., 2003), thedissect a now resurgent area of immunology. Despite
presence of cytokines (IL-10) (Groux et al., 1996), anda vast literature during the 1970s, the study of suppres-
cell surface ligands (jagged-1) (Hoyne et al., 2000).sor T cells had been largely abandoned until the publi-
Despite the large number of papers examining TR biol-cation of several seminal papers rekindled interest in
ogy, many questions about these cells remain. What iswhat are today generally referred to as regulatory T
their antigen specificity and affinity? Are there specific(TR) cells. The identification of the transcription factor
markers for their identification? How are these cells in-Foxp3 as the gene responsible for the defect in scurfy
duced in the thymus and in the periphery? By whatmice, and subsequently, the demonstration of its criti-
mechanism do they prevent disease in vivo? Clearly, acal involvement in the generation of TR cells, provides
more detailed molecular understanding of these subsetsan important molecular insight into this essential cell
of cells is required, and the identification of the genelineage.
responsible for disease in scurfy animals has unexpect-
edly provided one clue to this puzzle.Introduction
Identification and Characterization of Foxp3The recent interest in TR cells follows from observations
Initial studies of scurfy mice indicated that CD4 T cellsby Sakaguchi and colleagues indicating that naturally
from these mice were hyperresponsive to stimulation,occurring CD425 T cells were capable of preventing
produced a wide variety of cytokines, and that adoptiveautoimmunity in vivo (reviewed in Shevach, 2000). In
transfer into to SCID or nu/nu recipients induced a rapidaddition to autoimmunity, TR cells have been implicated
wasting disease (Blair et al., 1994). Overall, the pheno-in transplantation tolerance in rodent model systems,
type resembled that of animals deficient in either CTLA-4and ex vivo studies indicate that similar cells exist in
or TGF. Further, TCR transgenic scurfy animals had ahumans. Despite the large number of both in vivo and
greatly prolonged lifespan, suggesting that CD4 T cellin vitro studies examining TR cell biology, there is still recognition of endogenous self-antigens was requiredonly a rudimentary knowledge of the molecular mecha-
for pathology. The gene responsible for disease wasnisms that govern the development and activity of such
identified as a novel member of the forkhead/winged-cells.
helix family of transcriptional regulators and was desig-TR cells can be delineated into two broad subsets: nated Foxp3 (Brunkow et al., 2001). In addition to the
naturally occurring cells with suppressive activity and
forkhead domain, the protein (referred to as scurfin) also
those that are induced following stimulation (Bluestone
contains a single C2H2 Zinc finger and an apparent
and Abbas, 2003; Shevach, 2002). The former are most leucine-zipper motif. The gene is highly conserved in
commonly characterized by the constitutive presence humans and appears to have a similar function because
of CD25, although they also express a number of other mutations within FOXP3 result in a severe autoimmune
markers of activation including CD134 (OX40), GITR syndrome referred to as IPEX (Bennett et al., 2001; Chat-
(TNFRSF18), CD62L (L-selectin), and CD152 (Ctla-4). ila et al., 2000; Wildin et al., 2001).
These cells represent a minor (5%–10%) component of Little is known about the biochemistry of scurfin. Al-
CD4 T cells but possess potent suppressive activity though predicted to be a transcriptional regulator, no
both in vivo and in vitro. Using in vitro assays, these consensus DNA binding sequence or protein partners
cells mediate their suppressive effects in a cell contact- have been identified and it is unclear how the protein
dependent, antigen-independent manner, without the is regulated. Unlike a number of other family members,
requirement of IL-10 or TGF. Such cells are naturally there is no PKB/AKT consensus site for phosphoryla-
“anergic” but require stimulation via their TCR for opti- tion. In vitro assays have indicated that scurfin can act
mal suppressive function. The mechanism by which as a transcriptional repressor using an IL-2 promoter-
these cells function in vivo is likely more complex as a based reporter assay (Schubert et al., 2001), but the
role for IL-10 or TGF has been shown in a number of actual in vivo targets of scurfin are yet to be defined.
experimental systems. Association of Foxp3 with Natural (CD425) TR Cells
Another class of TR cells has also been described in A detailed study of Foxp3 mRNA indicated that expres-
which CD425– T cells are induced to develop regulatory sion was isolated to CD425 T cells, both in the periph-
ery and in the thymus (Figure 1). Standard activation
conditions using antibodies to the TCR and CD28 failed*Correspondence: fred.ramsdell@celltechgroup.com
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Figure 1. A Potential Model for Foxp3 in TR Development
Foxp3 expression occurs during thymic selection as a consequence of affinity for self-ligand or specific antigen-bearing cells. Continued
expression of Foxp3 is required for natural TR function in the periphery, and may be involved in the generation of induced TR cells following
tolerogenic stimulation of T cells.
to significantly induce Foxp3 mRNA in either CD425 poorly to T cell stimulation compared to Foxp3-negative
cells. This is true for both proliferative responses as wellor CD425– mouse cells, suggesting that this was not
simply a marker of activation. This separates scurfin as cytokine production, including IL-2 and IL-10. Using
cells from the mixed bone marrow chimeras, Fontenotfrom other TR “markers” such as CD25 and GITR which,
although useful, are expressed more generally on acti- et al. (2003) suggest that Foxp3-expressing CD425
proliferate normally to TCR stimulation. In addition, datavated T cells. At present, Foxp3 appears to be the gene
best correlated with CD425 TR cells. from the latter group indicates that expression of Foxp3
correlates with increased amounts of IL-10 mRNA.The association of Foxp3 mRNA expression with TR
cells suggested a potential functional linkage as well. Whether these differences in T cell function relate to the
amount of scurfin present, the method of cell purifica-The autoimmune pathologies noted in both mice and
humans lacking a functional Foxp3 gene product further tion, or variations in in vivo differentiation is unclear at
present. It should also be noted that both retrovirallyindicated that scurfin was involved in controlling T cell
activity. To test this directly, several groups expressed transduced cells and Foxp3 transgenic cells are not as
efficient at inhibition of CD425 T cell proliferation inFoxp3 in non-TR cells and examined their phenotype
and function. Using either retroviral transduction (Fon- vitro as “natural” CD425 T cells. This may be due to
heterogeneity within these populations as it is impossi-tenot et al., 2003; Hori et al., 2003) or transgenic animals
(Khattri et al., 2003), overexpression of Foxp3 resulted ble to determine whether all Foxp3 expressing cells also
express scurfin and whether all scurfin expressing cellsin the acquisition of in vitro TR activity by cells that did
not (initially) express a TR phenotype, including in one are in fact TR in nature. While the presence of scurfin
can clearly direct cells to the TR lineage, there are otherstudy CD8 cells. Further, the “non-TR cells” that ex-
pressed Foxp3 were capable of inhibiting disease in factors required for optimal function of these cells.
Foxp3 Association with Induced (CD425) TR Cellsvivo. A substantial portion of Foxp3-bearing cells also
expressed both CD25 and GITR constitutively, similar As mentioned earlier, TR cells can be thought of as both
naturally occurring cells and those cells induced by stim-to wild-type TR cells. Finally, in mixed bone marrow chi-
meras containing both Foxp3 and Foxp3null cells, it was ulation. The mechanism of action of induced regulatory
cells generally involves the production of cytokines suchdemonstrated that all CD425 TR cells that developed
were of Foxp3 origin. Thus, Foxp3 is able to control as IL-10 and TGF, a distinction from CD425 (Foxp3)
cells, and would suggest that perhaps these inducedthe development of TR cells.
The data from both Hori et al. (2003) and Khattri et al. cells do not express Foxp3. Although this must be con-
firmed experimentally, the expression of Foxp3 may(2003) indicate that cells overexpressing Foxp3 respond
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commit cells to a natural, CD425 lineage whereas Foxp3. Unless CD425 peripheral T cells express
“induced” TR cells represent an alternative state of T cell scurfin following specific in vivo stimulatory conditions,
differentiation based on the signals provided during the most logical model however would suggest that the
stimulation. primary role for scurfin is in the generation and poten-
FoxP3 may however, be involved in inducing another, tially maintenance of natural CD425 TR cells, repre-
yet to be described, population of cells to possess regu- senting a distinct T cell lineage.
latory activity. The phenotype of animals lacking scurfin Concluding Thoughts
is far more dramatic than most of the experimental func- Although the functional association of Foxp3 with TR
tions ascribed to CD425 TR cells in vivo. While scurfy cells provides a significant step forward in our under-
mice succumb to their autoimmune disease within ap- standing of these cells at the molecular level, there re-
proximately 3 weeks of age, absence of TR cells results main many questions about the mechanism by which
in autoimmunity, but not such a rapidly lethal pheno- Foxp3 exerts its effect. Whether this represents a lin-
type. One model to explain this disparity is that the eage commitment gene for TR cells in a manner similar
absence of scurfin during thymic development permits to T-bet for Th1 or GATA-3 for Th2 cells is suggested
the “escape” of self-reactive cells possessing an affinity by the current data but requires further proof. Whether
that would normally be diverted toward a regulatory Foxp3 is associated with other, non-CD25 TR cells is
phenotype by scurfin. The activity of such self-reactive similarly unknown, although the presence or absence
cells might account for the dramatic pathology seen in of Foxp3 may help identify these subsets. Current stud-
Foxp3null animals, particularly if the generation of other ies will soon determine if Foxp3 is induced in any of the
(or induced) TR cells also requires the expression of adaptive subsets of TR cells, and whether this correlates
Foxp3. with their functional activity. Although the association
Induction of Foxp3 is strong, it is nonetheless possible that Foxp3 will have
The factors that result in the induction of the Foxp3 functions outside that of TR biology directly, perhaps in
gene, and the cell populations that can express the regulating cytokine production from CD4 T cells. At the
gene, will ultimately help to determine the mechanism(s) very least, the introduction of this novel gene into the
by which TR cells are generated. CD425 TR cells devel- landscape of lymphocyte signaling will provide a more
op during thymic selection and Foxp3 mRNA could be detailed understanding of the diversification of T cell
controlled directly by the affinity of TCR interactions differentiation as well as a tool for the further dissection
during selection. Alternately, a subset of thymic antigen- of a once nearly abandoned area of immunology.
presenting cells, such as medullary thymic epithelial
cells expressing AIRE, might be involved in the genera-
Selected Reading
tion of CD425 TR cells. This is an attractive model
as these cells are clearly involved in the generation of Anderson, M.S., Venanzi, E.S., Klein, L., Chen, Z., Berzins, S.P.,
tolerance to tissue-specific antigens (Anderson et al., Turley, S.J., von Boehmer, H., Bronson, R., Dierich, A., Benoist, C.,
2002; Liston et al., 2003), although there are no data to et al. (2002). Science 298, 1395–1401.
support this at present. Whether a Foxp3 subset of TR Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson,
cells is also generated in peripheral tissues, and the P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and
Ochs, H.D. (2001). Nat. Genet. 27, 20–21.factors that might control this, has yet to be determined.
Expression of this gene during thymic development Blair, P.J., Bultman, S.J., Haas, J.C., Rouse, B.T., Wilkinson, J.E.,
and Godfrey, V.L. (1994). J. Immunol. 153, 3764–3774.alone is not sufficient to protect otherwise Foxp3null ani-
mals from disease (Khattri et al., 2001). This indicates Bluestone, J.A., and Abbas, A.K. (2003). Nat. Rev. Immunol. 3,
that continued Foxp3 expression within peripheral tis- 253–257.
sues is necessary, either for the maintenance or the Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B.,
function of TR cells, for the induction of TR cells extrathy- Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell,
F. (2001). Nat. Genet. 27, 68–73.mically, or for another function of scurfin that has yet
to be fully characterized. Although the data for Foxp3 Chatila, T.A., Blaeser, F., Ho, N., Lederman, H.M., Voulgaropoulos,
induction of TR activity are compelling, it is not clear C., Helms, C., and Bowcock, A.M. (2000). J. Clin. Invest. 106,
R75–R81.whether this is the only function for the scurfin protein.
CD4 T cells that overexpress scurfin are hyporespon- Fontenot, J.D., Gavin, M.A., and Rudensky, A.Y. (2003). Nat. Immu-
nol. 4, 330–336.sive to stimulation and are defective in their cytokine
production, possibly accounting for their suboptimal Groux, H., Bigler, M., De Vries, J.E., and Roncarolo, M.G. (1996). J.
Exp. Med. 184, 19–29.suppressive activity. In addition, the amount of Foxp3
mRNA in transgenic mice is directly correlated with the Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S., De
number of peripheral T cells. This could represent the Vries, J.E., and Roncarolo, M.G. (1997). Nature 389, 737–742.
limited homeostatic expansion capacity of TR (Foxp3) Hori, S., Nomura, T., and Sakaguchi, S. (2003). Science 299, 1057–
cells or a direct effect of scurfin on overall T cell expan- 1061.
sion. Because Foxp3null and Ctla-4null mice display a very Hoyne, G.F., Le Roux, I., Corsin-Jimenez, M., Tan, K., Dunne, J.,
similar phenotype, it is important to note that transgenic Forsyth, L.M., Dallman, M.J., Owen, M.J., Ish-Horowicz, D., and
expression of Foxp3 can dramatically delay the lethality Lamb, J.R. (2000). Int. Immunol. 12, 177–185.
in Ctla-4null mice, although not completely prevent dis- Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., and Enk, A.H. (2000).
ease (Khattri et al., 2003). That these Ctla-4null/Foxp3 J. Exp. Med. 192, 1213–1222.
transgenic mice possess CD425 TR cells suggests Khattri, R., Kasprowicz, D., Cox, T., Mortrud, M., Appleby, M.W.,
that these TR cells can delay disease, although there Brunkow, M.E., Ziegler, S.F., and Ramsdell, F. (2001). J. Immunol.
167, 6312–6320.could also be a direct link between Ctla-4 signaling and
Immunity
168
Khattri, R., Cox, T., Yasayko, S.A., and Ramsdell, F. (2003). Nat.
Immunol. 4, 337–342.
Levings, M.K., Sangregorio, R., Galbiati, F., Squadrone, S., de Waal,
M.R., and Roncarolo, M.G. (2001). J. Immunol. 166, 5530–5539.
Liston, A., Lesage, S., Wilson, J., Peltonen, L., and Goodnow, C.C.
(2003). Nat. Immunol. 4, 350–354.
Schubert, L.A., Jeffery, E., Zhang, Y., Ramsdell, F., and Ziegler, S.F.
(2001). J. Biol. Chem. 276, 37672–37679.
Shevach, E.M. (2000). Annu. Rev. Immunol. 18, 423–449.
Shevach, E.M. (2002). Nat. Rev. Immunol. 2, 389–400.
Sundstedt, A., O’Neill, E.J., Nicolson, K.S., and Wraith, D.C. (2003).
J. Immunol. 170, 1240–1248.
Thorstenson, K.M., and Khoruts, A. (2001). J. Immunol. 167, 188–195.
Wakkach, A., Fournier, N., Brun, V., Breittmayer, J.P., Cottrez, F.,
and Groux, H. (2003). Immunity 18, 605–617.
Wildin, R.S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.L.,
Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al.
(2001). Nat. Genet. 27, 18–20.
